Diffuse Heavy Calcified Lesion of RCA Treated by Rotablation

Operator: Seung-Jung Park, MD

- Case Presentation: A 66-year-old male patient was admitted for further evaluation of thallium-SPECT abnormality for the regular surveillance after PCI. He underwent PCI at the LAD and RCA 11 years ago. The SPECT showed reversible large sized perfusion defect in anterolateral and inferolateral wall. His coronary angiography demonstrated patent previous coronary artery stents, but significant stenosis at the RCA with diffuse heavy calcification in the setting of the RCA dominant coronary system. His coronary arterial risk factor was hypertension. The physical examination and electrocardiogram were unremarkable. Echocardiography revealed moderate left ventricular systolic dysfunction with akinesia of posterolateral and mid anterior wall...More
V Stenting Technique to Severely Calcified ISR Lesions in Trifurcation with Protected LAD

Operator: Jung-Min Ahn, MD

- Case Presentation: A 63 years old male patient visited to emergency department for chest pain during hemodialysis. He underwent CABG (LIMA to LAD, SVG to diagonal branch to PDA) 2 months ago. He also had history of prior PCI at LCX and RI 20 years before with BMSs. Because cardiac enzyme elevation was identified at the emergency department, he was hospitalized and underwent echocardiogram and coronary angiogram. Echocardiography showed reduced EF (49%) without regional wall motion abnormality, and CAG showed tight and calcified in-stent restenosis at trifurcation involving the LAD, LCX, and RI. As the LAD was protected with LIMA, we planned to treat LCX and RI lesions...More
  • Complex PCI
  • TCTAP
  • AP VALVES

CardioVascular Research Foundation (CVRF)
2nd Floor, Asan Institute for Education & Research, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea
Tel_82.2.3010.4792 | Fax_82.2.475.6898
재단법인 심장혈관연구재단
대표이사 박승정 | 서울시 송파구 올림픽로43길 88, 서울아산병원 아산교육연구관 2층 | 사업자등록번호 215-82-06387
개인정보 관리책임자_노순정 | 전화번호_02.3010.4792 | 팩스번호_02.475.6898
Copyright © CVRF, Seoul, Korea. All rights reserved.